Among the groups leading the way are those devoted to global vaccine development, which already partner with firms to bring vaccine programs closer to fruition. (scientificamerican.com)
Besides immunologists or virologists, «there are many kinds of scientists entering the field who weren't there before», says Rino Rappuoli, head of global vaccines research for Novartis in Siena, Italy. (newscientist.com)
GlaxoSmithKline (GSK) today will officially open its newest global vaccines R&D center in Rockville, MD, where the pharma giant will base 450 researchers and support staffers and spend $ 50 million over the next 2 years on technology and equipment. (genengnews.com)